期刊文献+

氧化苦参碱对致敏小鼠气道高反应性和炎症的影响 被引量:3

The effects of oxymatrine on allergen-induced airway hyperresponsiveness and inflammation in mice
原文传递
导出
摘要 目的:观察氧化苦参碱对致敏小鼠气道高反应性和炎症的影响。方法:采用卵白蛋白致敏小鼠,反复攻击后形成小鼠哮喘模型。静脉注射乙酰甲胆碱(Mch)激发哮喘小鼠的气道高反应性,测定肺阻力(RL)和动态肺顺应性(Cdyn)。用支气管肺灌洗液(BALF)检测气道炎症细胞的浸润。结果:哮喘模型组与正常组小鼠比较,气道反应性明显增高,BALF中白细胞总数和嗜酸性粒细胞数目明显增多。氧化苦参碱50?150?450mg/kg灌胃给药呈剂量依赖抑制小鼠的气道高反应性和炎症反应。结论:氧化苦参碱能防治小鼠支气管哮喘,为氧化苦参碱运用于临床提供实验依据。 Objective: We evaluated the effect of oxymatine on allergen-induced airway hyperresponsiveness (AHR) and inflammation in mice. Methods: Sensitized mice were challenged with aerosolized ovalbumin for 7 days, oxymatine (50, 150 and 450mg/kg) and dexamethasone ( DXM 2mg/kg) were orally administered once daily during the period of challenge. AHR to methacholine (Mch) was determined by whole- body plethysmography. We measured the airway resistance and dynamic compliance of mice and evaluated the inflammationory cells in BALF. Results : The model mice had significantly greater AHR than the control mice, development of AHR and the inflammation recreation was dosage dependently attenuated in mice that received oxymatine treatment. The inflammationory cells in BALF were significantly increased in model mice compared with control mice. Conclusion: these results suggest that oxymatine represents a potential new drug for the treatment of asthma.
作者 周琴 孙建刚
出处 《中药药理与临床》 CAS CSCD 北大核心 2009年第1期21-23,共3页 Pharmacology and Clinics of Chinese Materia Medica
关键词 氧化苦参碱 气道高反应性 嗜酸性粒细胞 卵白蛋白 哮喘 oxymatine airway hyperresponsiveness eosinophil ovalbuim asthma
  • 相关文献

参考文献10

  • 1Fred WW, Diana KS. Advances in Immunopharmacology of Asthma. Biochem Pharmacol, 2000;59: 1323 - 1355
  • 2Eduard E, Talissa A, James T, et al. The variability of regional airflow obstruction within the lungs of patients with asthma: Assessment with hyperpolarized helium-3 magnetic resonance imaging. Journal of Allergy and Clinical Immunology, 2007; 199(5): 1072 -1075
  • 3John HK, Randall WB, Stanley MF, et al. Asthma and the unified airway. Otolaryngology - Head and Neck Surgery, 2007;136(5): S75 -S106
  • 4Wilion JW, Bamford TL. Assessing the evidence for remodelling of the airway in asthma. Pulmon Pharmacol and Ther, 2001 ; 14:229 -247
  • 5Xie QM, Chen JQ, Shen WH, el al. Effects of cyclosporin A by aerosol on airway hypcrresponsiveness and inflammation in guines pigs. Acta Pharmacol Sin, 2002;23(3): 237 -242
  • 6Toshihiro S, Kentaro U, Ryutaro H , et al. Small airway changes in healthy and ovalbumin-treated mice during quasi-static lung inflation. Respiratory Physiology & Neurobiology, 2007;156(3): 304-311
  • 7Liesker J J, ten H, Rutgers SR, et al. Mast cell numbers in airway smooth muscle and PC20AMP in asthma and COPD. Respiratory Medicine, 2007 ; 101(5): 882 -887
  • 8Boot JD, Panzner P, Diamant Z. A critical appraisal of methods used in early clinical development of novel drugs for the treatment of asthma. Pulmonary Pharmacology & Therapeutics, 2007 ;20 ( 3 ) : 201 - 219
  • 9Zuzana D, Diderik JB, Christian JV. Summing up 100 years of asthma. Respiratory Medicine, 2007;101(3): 378 -388
  • 10Nicola S, Kenneth JB. Optimisation of the sensitisation conditions for an ovalbumin challenge model of asthma. International Immunopharmacology, 2007; 7(2): 183 -190

同被引文献54

引证文献3

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部